GPC3 also interacts with the YAP pathway, promoting either oncogenic activity or tumor suppression, contingent on the specific cellular environment and context.[11] Alterations in these pathways can impact immune cell migration, infiltration, and function, thereby modifying the immune response within the TME. Here, GPC3 is linked to neoplasm.